Galectin's belapectin shows promise in MASH cirrhosis despite setbacks. High-risk investment with upcoming FDA meeting ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the ...

These are the upcoming stock splits for the week of August 25 to August 29, based on TipRanks’ Stock Splits Calendar. A stock ...

Merck & Company Inc. is currently navigating a complex market landscape. The near and mid-term outlook for the company shows ...

Berkshire Hathaway is about to make the biggest change in its business since Warren Buffett took over the company.

Merck & Company Inc. shows a promising near and mid-term outlook despite a shaky long-term perspective. Currently, there's no ...